October 2021 • PharmaTimes Magazine • 4-5


Image

Contents


News Review

Features

Meeting expectations when it comes to climate change, carbon emissions and sustainability


Oli Hudson looks at three practical implications for pharma companies


Prioritising safety


Extracting value from the lessons of COVID-19 to empower people living with HIV


Analysis

Looking at key opportunities for the NHS


Are employers doing enough to fulfil their duty of care?


A revolution for biopharma?


Legal risks for NHS data sharing


How to bring worldwide AE reporting under control


Should pharma companies consider protecting colours that are key to their products?


SmartPeople

PharmaTimes talks to Rick Thompson, chief executive officer at Findacure, and Lucy McKay, chief executive officer at Medics4RareDiseases, about the government's UK Rare Disease Framework


PharmaTimes talks to Jess Page about living with a bleeding disorder